The Independent Examinations Board (IEB) has achieved an overall pass rate of 98.31% for the 2025 matric exams.

New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...

KNOXVILLE, TN, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Daisy Genomics Inc. (“Daisy Genomics”) and New Day ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for ...

A look at Exact Sciences Corporation’s acquisition by Abbott: review EXAS revenue growth, margins, and CRC/MRD screening ...

The STELLAR-316 trial will use Natera's Signatera assay to identify MRD-positive patients for trial enrollment and to monitor therapy response.

Initiation of eAArly DETECT 2 - U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over ...